InvestorsHub Logo
Followers 28
Posts 344
Boards Moderated 0
Alias Born 07/23/2013

Re: Lnp30 post# 18444

Thursday, 10/23/2014 10:04:25 AM

Thursday, October 23, 2014 10:04:25 AM

Post# of 55010
Lnp, I think your numbers are correct. I do not, however, think that is all there is to payments that may came from BAT. There is another part of the contract laid out in section 3.09 that describes payments each company makes to the other based on sales. It is part of the non-exclusive term of the contract, which I believe overlaps the 2nd and 3rd commercial terms. During that time, each company pays 50% of their profit from sales to the other. Good chance BAT sales will significantly exceed XXII given their global reach.

I think the payments you refer to are payment just related to the genetic technology, not sales. I would attach the wording from section 3.09 but I have a hike to lead. Will catch up tonight.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News